Rod Wong

Rod Wong, founder and CIO of RTW Investments, and Stephanie Sirota, its Chief Business Officer, dive deep into the unique landscape of healthcare investing. They tackle the complexities of drug investment phases and the crucial role of regulations. The guests compare founder-led biotech startups to larger firms, highlighting the societal impacts of innovations. They also discuss the evolution of investment strategies in biotech and the challenges posed by an ever-shifting pharmaceutical landscape, including pricing and M&A dynamics.

Rod Wong, managing partner at RTW Investments and rare-disease backer, discusses a coalition pushing for clearer FDA rules. He covers why regulatory predictability matters to investors. Conversations also touch on pharma M&A activity and Eli Lilly’s move into sleep medicines.

Rod Wong, Founder and Managing Partner of RTW Investments, shares his insights on the often-overlooked opportunities in biotech. He discusses his unique journey from aspiring doctor to leader in life sciences investment. The conversation dives into navigating the volatility of biotech, the importance of innovation like genomic advancements, and the strategic shift from stock picking to lifecycle investing. Wong also emphasizes effective communication and team dynamics as keys to success in this competitive field.